Efficacy and safety of direct oral anticoagulants versus low-molecular-weight heparin in patients with cancer: a systematic review and meta-analysis
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Thrombosis and Thrombolysis"
DOI: 10.1007/s11239-019-01871-4
Abstract: The efficacy and safety of direct oral anticoagulants (DOACs) versus low-molecular-weight heparin (LMWH) are still debated in the treatment of patients with cancer, and the optimal duration of therapy remains uncertain. Electronic databases (PubMed, Embase,… read more here.
Keywords: cancer; efficacy safety; safety direct; patients cancer ... See more keywords
Efficacy and safety of direct‐acting antiviral‐based treatment in hepatitis C virus infected patients with chronic renal function impairment: An updated systemic review and meta‐analysis
Sign Up to like & getrecommendations! Published in 2020 at "Nephrology"
DOI: 10.1111/nep.13704
Abstract: To further determine the efficacy and safety of direct‐acting antiviral (DAA)‐based treatments in hepatitis C virus (HCV) infected patients with renal function impairment. read more here.
Keywords: efficacy safety; safety direct; direct acting; acting antiviral ... See more keywords
Efficacy and safety of direct oral anticoagulants (DOACs) and low molecular weight heparin (LMWH) for primary prevention of venous thromboembolism (VTE) in ambulatory cancer patients.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.15_suppl.12088
Abstract: 12088Background: Active malignancy is a well described risk factor for thrombosis. Randomized clinical trials (RCT) have evaluated anticoagulation (AC) with DOACs or LMWH for prevention of VTE in a... read more here.
Keywords: efficacy safety; oral anticoagulants; safety direct; direct oral ... See more keywords